NAVIDEA BIOPHARMACEUTICALS I (NAVB) Stock News

USA - NYSEARCA:NAVB - US63937X2027 - Common Stock

0.0779 USD

0 (-2.99%)

Last: 10/5/2023, 8:04:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NAVB Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. Files for Bankruptcy

6 months ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. Announces Extension of Authority to Implement a Reverse Stock Split

7 months ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals Announces the Extension of Plan Designed to Protect NOLs and Other Tax Assets

a year ago - By: Navidea Biopharmaceuticals, Inc. - Mentions: OTC

Navidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024

2 years ago - By: InvestorPlace - Mentions: SOFI PLTR SONN

Why Is SOFI Stock Up 19% Today?

2 years ago - By: Benzinga

Why Navidea Biopharmaceuticals Shares Are Nosediving

a year ago - By: Navidea Biopharmaceuticals, Inc. - Mentions: OTC

Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024

2 years ago - By: Navidea Biopharmaceuticals, Inc. - Mentions: OTC

Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations

2 years ago - By: Seeking Alpha

Navidea settles litigation with Capital Royalty, stock rallies 30% (NAVB)

2 years ago - By: Benzinga - Mentions: FUSN RGLS TTOO AHI ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

2 years ago - By: Navidea Biopharmaceuticals, Inc. - Mentions: OTC

Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release

2 years ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock

2 years ago - By: InvestorPlace - Mentions: CFFE CNXA ELUT CCG ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

2 years ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel

2 years ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities

2 years ago - By: InvestorPlace - Mentions: SONN AURC CHNR

Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?

2 years ago - By: InvestorPlace - Mentions: AURC CHNR

Why Is Navidea Biopharmaceutical (NAVB) Stock Down 13% Today?

2 years ago - By: InvestorPlace - Mentions: CHNR FOXO AURC ALLR ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

2 years ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination

2 years ago - By: Seeking Alpha

Navidea Biopharmaceuticals hires Craig Dais as CFO (NYSE:NAVB)

2 years ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer

2 years ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down

2 years ago - By: Navidea Biopharmaceuticals, Inc.

Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets

2 years ago - By: InvestorPlace - Mentions: AHI LMDX BSFC ANY ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday